Article
Development of Staphylococcus aureus tolerance to antimicrobial photodynamic inactivation and antimicrobial blue light upon sub-lethal treatment
1 Jul 2019
Abstract excerpt
Abstract Antimicrobial photodynamic inactivation (aPDI) and antimicrobial blue light (aBL) are considered low-risk treatments for the development of bacterial resistance and/or tolerance due to their multitargeted modes of action. In this study, we assessed the development of Staphylococcus aureus tolerance to these phototreatments. Reference S . aureus USA300 JE2 was subjected to 15 cycles of both sub-lethal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
